NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-093-1996-3-CA-20 O2-Glycosylated 1-Substituted Diazen-1-Um-1,2-Diolates CA DIV 2814748 Expired
NCI E-093-1996-3-EP-08 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES EP DIV 04009529.1 Expired
NCI E-093-1996-3-CA-18 O2-Glycosylated 1-Substituted Diazen-1-Um-1,2-Diolates CA DIV 2705474 Expired
NCI E-093-1996-3-CA-04 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES CA National Stage 2266908 Expired
NCI E-093-1996-3-JP-05 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES JP National Stage 1998-515924 Expired
NCI E-093-1996-3-DE-10 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES DE EP 97944471.8 Expired
NCI E-093-1996-3-FR-11 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES FR EP 97944471.8 Expired
NCI E-093-1996-3-BE-15 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES BE EP 97944471.8 Expired
NCI E-093-1996-3-IT-13 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES IT EP 97944471.8 Expired
NCI E-093-1996-3-IE-12 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES IE EP 97944471.8 Expired
NCI E-093-1996-3-CH-14 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES CH EP 97944471.8 Expired
NCI E-093-1996-3-GB-09 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES GB EP 97944471.8 Expired
NCI E-093-1996-3-EP-02 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES EP National Stage 97944471.8 Expired
NCI E-093-1996-3-AU-03 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES AU National Stage 45957/97 Expired
NCI E-093-1996-3-PCT-01 O2-ARYLATED OR O2-GLYCOSYLATED 1-SUBSTITUTED DIAZEN-1-IUM-1,2-DIOLATES AND O2-SUBSTITUTED 1-[(2-CARBOXYLATO)PYRROLIDIN-1-YL]DIAZEN-1-IUM-1,2-DIOLATES PCT PCT COMB PCT/US1997/017267 Expired
NIAID E-179-1997-1-US-01 METHOD FOR INHIBITION OF HIV-1 REPLICATION US 60/060,124 Abandoned
NCI E-265-1994-1-US-01 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE INT6 US CIP 08/875,847 6255105 Abandoned PDF
NHLBI E-172-1997-0-US-02 METHOD FOR EXTRACTING DEFORMATIONS FROM VELOCITY-ENCODED MAGNETIC RESONANCE IMAGES OF THE HEART US ORD 08/937,725 6031374 Expired PDF
NEI E-078-1997-0-US-01 ANIMAL MODEL FOR AGE-RELATED MACULAR DEGENERATION AND METHODS FOR USE THEREOF US 60/060,045 Abandoned
NIAID E-101-1995-1-US-02 ISOLATED EPSTEIN-BARR VIRUS BZLF2 PROTEINS THAT BIND MHC CLASS II BETA CHAINS US DIV 08/936,854 5925734 Expired PDF
NHGRI E-135-1996-0-PCT-02 RETROVIRAL PACKAGING CASSETTES AMPLIFIED IN THE CYTOPLASM BY AUTOCATALYTIC TOGAVIRUS VECTORS PCT PCT PCT/US1997/017049 Expired
NIDDK E-279-2000-0-US-03 Purine nucleotide anoalogues, pharmaceutical compositions thereof, and methods of improving cardiac functions US National Stage 08/875,050 6255292 Expired PDF
NCI E-424-1987-0-US-04 Method of Treating Inflammation with Antibodies to Neutrophil Chemotactic Factor (As Amended). US DIV 08/935,560 5925352 Expired PDF
NICHD E-085-1996-0-US-01 NUCLEOTIDE AND AMINO ACID SEQUENCES OF THE BRX GENE AND GENE PRODUCT, AND USES THEREOF US 60/059,621 Abandoned
NCI E-053-1996-0-US-03 IMMORTAL HUMAN PROSTATE EPITHELIAL CELL LINES AND THEIR APPLICATIONS IN THE RESEARCH AND THERAPY OF PROSTATE CANCER US National Stage 08/913,770 6982168 Abandoned PDF
NCI E-132-1988-0-US-06 8-CI Camp as Anti-Cancer Drug US CON 08/937,020 5902794 Abandoned PDF
NIAID E-049-1998-0-PCT-02 3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGA VIRALES PCT PCT PCT/US1997/016718 Expired
NIAID E-094-1999-0-US-01 Attenuated Respiratory Syncytial Viruses US 60/059,552 Abandoned
NCI E-160-1996-0-US-01 METHODS FOR USE OF INTERLEUKIN 4 (IL-4) AND TUMOR NECROSIS FACTOR ALPHA (TNF-A) TO TREAT HUMAN IMMUNODEFICIENCY VIRUS INFECTION US 60/059,359 Abandoned
NIAID E-089-1997-1-US-01 PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES US 60/059,385 Abandoned
NIAID E-049-1998-0-BR-04 3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES BR National Stage PI9712138-0 Expired
NIAID E-049-1998-0-AU-03 3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES AU National Stage 44278/97 Abandoned
NIAID E-049-1998-0-CA-05 3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES CA National Stage 2265554 Abandoned
NHLBI E-263-1997-0-US-01 SPONTANEOUS BREATHING APPARATUS AND METHOD US 60/059,251 Abandoned
NHLBI E-263-1997-0-US-02 SPONTANEOUS BREATHING APPARATUS AND METHOD US ORD 08/933,003 Abandoned
NIAID E-176-1996-0-PCT-02 HIV-1 THERAPY WITH IL-2 AND ANTI-TNF ANTIBODY PCT PCT PCT/US1997/16116 Abandoned
NIDCR E-171-1996-0-EP-07 TARGETING ANTIGENTS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN EP National Stage 97941660.9 Abandoned
NIDCR E-171-1996-0-GB-11 TARGETING ANTIGENTS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN GB EP 97941660.9 Abandoned
NIDCR E-171-1996-0-DE-09 TARGETING ANTIGENTS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN DE EP 97941660.9 Abandoned
NIDCR E-171-1996-0-FR-10 TARGETING ANTIGENTS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN FR EP 97941660.9 Abandoned
NIDCR E-171-1996-0-AU-05 TARGETING ANTIGENTS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN AU National Stage 43521/97 Abandoned
NIDCR E-171-1996-0-CA-06 TARGETING ANTIGENS TO THE MHC CLASS I PROCESSING PATHWAY WITH ANTHRAX TOXIN FUSION PROTEIN CA National Stage 2265852 Abandoned
NIDCR E-171-1996-0-US-02 TARGETING ANTIGENTS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN US ORD 08/937,276 6592872 Abandoned PDF
NINDS E-132-1996-0-US-02 AN Immunotoxin (mAB-RICIN) For The Treatment of Focal Movement Disorders US ORD 08/937,266 Abandoned
NIAID E-188-1992-0-US-04 REGULATION OF T CELL EFFECTOR ACTIVITY BY T CELL RECEPTOR LIGANDS WITH INCOMPLETE AGONIST (MIXED AGONIST-ANTAGONIST) PROPERTIES US CON 08/931,192 Abandoned
NIAID E-248-1997-0-US-01 PLASMODIUM FALCIPARUM GENE LINKED TO CHLOROQUINE RESISTANCE IN HUMAN MALARIA US 60/058,895 Abandoned
NCI E-194-1994-1-US-02 Substituted O6-Benzylguanines and 6 (4)-Benzyloxypyrimidines US DIV 08/927,846 5916894 Abandoned PDF
NIDDK E-145-1995-0-PCT-02 THE USE OF FUNCTIONAL N-METHYL-D-ASPARTATE ANTAGONISTS TO AMELIORATE OR PREVENT AMINOGLYCOSIDE-INDUCED OTOTOXICITY PCT PCT PCT/US1997/016605 Abandoned
NIDCR E-066-1996-0-EP-06 AAV4 VECTOR AND USES THEREOF EP National Stage 97945204.2 Abandoned
NCI E-268-1997-0-US-01 MUCOSAL CYTOTOXIC T LYMPHOCYTE RESPONSES US 60/058,523 Abandoned